Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
J Neurooncol. 2024 Jan;166(2):273-282. doi: 10.1007/s11060-023-04555-5. Epub 2024 Jan 16.
J Neurooncol. 2024.
PMID: 38227143
Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with Temozolomide.
Eda T, Okada M, Ogura R, Tsukamoto Y, Kanemaru Y, Watanabe J, On J, Aoki H, Oishi M, Takei N, Fujii Y, Natsumeda M.
Eda T, et al.
Cancers (Basel). 2022 Feb 2;14(3):770. doi: 10.3390/cancers14030770.
Cancers (Basel). 2022.
PMID: 35159037
Free PMC article.
Item in Clipboard
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features.
Natsumeda M, Chang M, Gabdulkhaev R, Takahashi H, Tsukamoto Y, Kanemaru Y, Okada M, Oishi M, Okamoto K, Rodriguez FJ, Kakita A, Fujii Y, Schreck KC.
Natsumeda M, et al.
Brain Tumor Pathol. 2021 Jul;38(3):228-233. doi: 10.1007/s10014-021-00407-0. Epub 2021 Jul 3.
Brain Tumor Pathol. 2021.
PMID: 34216310
Item in Clipboard
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline Gliomas.
On J, Natsumeda M, Watanabe J, Saito S, Kanemaru Y, Abe H, Tsukamoto Y, Okada M, Oishi M, Yoshimura J, Kakita A, Fujii Y.
On J, et al.
Diagnostics (Basel). 2021 Apr 9;11(4):681. doi: 10.3390/diagnostics11040681.
Diagnostics (Basel). 2021.
PMID: 33918936
Free PMC article.
Item in Clipboard
Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy.
Kanemaru Y, Natsumeda M, Okada M, Saito R, Kobayashi D, Eda T, Watanabe J, Saito S, Tsukamoto Y, Oishi M, Saito H, Nagahashi M, Sasaki T, Hashizume R, Aoyama H, Wakai T, Kakita A, Fujii Y.
Kanemaru Y, et al.
Acta Neuropathol Commun. 2019 Jul 25;7(1):119. doi: 10.1186/s40478-019-0774-7.
Acta Neuropathol Commun. 2019.
PMID: 31345255
Free PMC article.
Item in Clipboard
Cite
Cite